Radiation 'Bullet' added to standard drug in major prostate cancer fight

NCT ID NCT02194842

Summary

This large, late-stage trial is testing if combining a standard hormone-blocking pill (enzalutamide) with a bone-targeted radiation treatment (Ra223) works better than the pill alone for men whose prostate cancer has spread to their bones and is no longer responding to standard hormone therapy. The main goal is to see if the combination can keep the cancer from getting worse for a longer time, delay bone pain, and help patients live longer. It is for men with few or no symptoms from their cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AZ Groeninge Kortrijk

    Kortrijk, Belgium

  • AZ Turnhout

    Turnhout, Belgium

  • Assistance Publique - Hopitaux de Paris - CHU Henri Mondor

    Créteil, 94000, France

  • CHU Dinant Godinne - UCL Namur

    Yvoir, 5530, Belgium

  • CHUM - Centre Hospitalier de l'Université de Montreal - Pavillon Saint-Luc

    Montreal, Quebec, H2X 3J4, Canada

  • Centre Francois Baclesse

    Caen, 14076, France

  • Centre Leon Berard

    Lyon, 69008, France

  • Centre de sante et de services sociaux de Chicoutimi

    Chicoutimi, Quebec, G7H 5H6, Canada

  • Centro Pesquisas Oncologicas

    Florianópolis, 88034000, Brazil

  • Centro de Estudos e Pesquisa Hematologia e Oncologia

    Santo André, 09060-650, Brazil

  • Centro de Pesquisas Clinicas em Oncologia - Hospital Sao Lucas

    Porto Alegre, 90610 000, Brazil

  • Centro de Tratamentos de Tumores Botafogo

    Rio de Janeiro, 22250-040, Brazil

  • Chuq-Pavillon Hotel-Dieu De Quebec

    Québec, Quebec, G1R 2J6, Canada

  • Cliniques Universitaires Saint-Luc

    Brussels, 1200, Belgium

  • Clínica Oncológica - CLION

    Salvador, 41810-570, Brazil

  • Complejo Hospitalario de Navarra

    Pamplona, 31008, Spain

  • Cork University Hospital

    Cork, TI2DC4A, Ireland

  • Corporacio Sanitaria Parc Tauli

    Sabadell, Spain

  • Gustave Roussy

    Villejuif, 94805, France

  • Hamilton And District Urology Association

    Hamilton, Ontario, L8N 1T8, Canada

  • Hopital Universitaire Brugmann

    Brussels, 1020, Belgium

  • Hopitaux Universitaires Bordet-Erasme - Hopital Universitaire Erasme

    Brussels, 1070, Belgium

  • Hopitaux Universitaires de Strasbourg - Hôpitaux Universitaires de Strasbourg - Hôpital civil

    Strasbourg, 67091, France

  • Hospital Beneficencia Portuguesa

    São Paulo, 01321-000, Brazil

  • Hospital Clinic Universitari de Barcelona

    Barcelona, 08036, Spain

  • Hospital De La Santa Creu I Sant Pau

    Barcelona, 08041, Spain

  • Hospital Del Mar

    Barcelona, 08003, Spain

  • Hospital Erasto Gaertner

    Curitiba, 81520-060, Brazil

  • Hospital Moinhos de Vento

    Porto Alegre, 90035-001, Brazil

  • Hospital Paulistano

    São Paulo, 01321-001, Brazil

  • Hospital Universitario QuironSalud

    Madrid, 28223, Spain

  • Hospital Universitario Ramon y Cajal

    Madrid, 28034, Spain

  • Hospital Universitario de La Princesa

    Madrid, 28006, Spain

  • Hospital Universitario de Salamanca

    Salamanca, 37007, Spain

  • Hospital de Amor

    Barretos, 14.784-400, Brazil

  • Institut de Cancerologie de l'Ouest (ICO) - Centre Paul Papin

    Angers, 49055, France

  • Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau

    Saint-Herblain, 44805, France

  • Institut régional du Cancer Montpellier

    Montpellier, 34298, France

  • Instituto de Medicina Integral Professor Fernando Figueira - IMIP

    Recife, 50070-550, Brazil

  • Istituto Europeo di Oncologia

    Milan, Italy

  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

    Meldola, Italy

  • Kantonsspital St Gallen

    Sankt Gallen, Switzerland

  • London Regional Cancer Center

    London, Ontario, N6A 4L6, Canada

  • Maria Sklodowska-Curie Memorial Cancer Centre

    Warsaw, Poland

  • Nottingham University Hospitals NHS Trust - City Hospital

    Nottingham, United Kingdom

  • Odette Cancer Centre - Sunnybrook Health Sciences Centre

    Toronto, Ontario, M4N 3M5, Canada

  • Oncocentro

    Fortaleza, 60130-241, Brazil

  • Oncology Institute of Southern Switzerland - Ospedale San Giovanni

    Bellinzona, 6500, Switzerland

  • Ospedale B.Ramazzini

    Carpi, 41012, Italy

  • Rigshospitalet

    Copenhagen, Denmark

  • Royal Marsden Hospital - Chelsea, London

    London, SW3 6JJ, United Kingdom

  • Saint John Regional Hospital

    Saint John, New Brunswick, E2L 4, Canada

  • Sao Camilo Oncologia - Instituto Brasileiro de Controle do Cancer

    São Paulo, 03.102-002, Brazil

  • Soerlandet Sykehus-Kristiansand

    Kristiansand, 4604, Norway

  • St. Vincent's University Hospital

    Dublin, Ireland

  • Tallaght University Hospital

    Dublin, Ireland

  • The Christie NHS Foundation Trust

    Manchester, United Kingdom

  • U.Z. Leuven - Campus Gasthuisberg

    Leuven, 3000, Belgium

  • United Lincolnshire Hospitals NHS Trust - Lincoln County Hospital

    Lincoln, LN2 5QY, United Kingdom

  • UniversitaetsSpital Zurich

    Zurich, 8091, Switzerland

  • Universitair Ziekenhuis Antwerpen

    Edegem, 2650, Belgium

  • University Health Network - Oci Princess Margaret Hospital

    Toronto, Ontario, M5G 2M9, Canada

  • University Hospital of North Norway

    Tromsø, N-9038, Norway

  • Vall d'Hebron Institut d'Oncologia

    Barcelona, 08035, Spain

Conditions

Explore the condition pages connected to this study.